Triggering of TRAIL-R1 and TRAIL-R2 death receptors by their selective fully human agonistic antibodies induces apoptosis in primary and cultured lymphoma cells

被引：0
|
作者：
Georgakis, G
Li, Y
Humphreys, R
Andreeff, M
O'Brien, S
Younes, M
Carbone, A
Albert, V
Younes, A
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Human Genome Sci, Rockville, MD USA
[3] Baylor Coll Med, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [31] Meta analysis for association of TRAIL DR4/TRAIL-R1 and DR5/TRAIL-R2 with hepatocelluar carcinoma prognosis
    Zhang, Lu
    Chen, Xiang-Jun
    He, Da
    Zhou, Tao-You
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (09): : 12995 - 13002
  • [32] Increased Expression of TRAIL and Its Death Receptors TRAIL-R1/2 Correlates with Progression of Radioactive Skin Injury
    Li, Huimin
    Li, Tong
    Dong, Jiahui
    Guo, Yisha
    Dou, Guifang
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2024, 38 (02): : 1723 - 1733
  • [33] Biomarkers for predicting the sensitivity of cancer cells to TRAIL-R1 agonistic monoclonal antibody
    Araki, Shinsuke
    Nakayama, Yusuke
    Hori, Akira
    Yoshimura, Koji
    CANCER LETTERS, 2010, 292 (02) : 269 - 279
  • [34] Receptor-selective TRAIL Mutants Target Lymphoid Tumor cells for Apoptosis via TRAIL-R1: Implications for Therapy
    MacFarlane, Marion
    Kohlhaas, Susan L.
    Sutcliffe, Michael J.
    Dyer, Martin J. S.
    Cohen, Gerald M.
    TOXICOLOGY, 2008, 253 (1-3) : 6 - 7
  • [35] TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2
    Taro Tamada
    Daisuke Shinmi
    Masahiro Ikeda
    Yasushi Yonezawa
    Shiro Kataoka
    Ryota Kuroki
    Eiji Mori
    Kazuhiro Motoki
    Scientific Reports, 5
  • [36] Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers
    Shin, MS
    Kim, HS
    Lee, SH
    Park, WS
    Kim, SY
    Park, JY
    Lee, JH
    Lee, SK
    Lee, SN
    Jung, SS
    Han, JY
    Kim, H
    Lee, JY
    Yoo, NJ
    CANCER RESEARCH, 2001, 61 (13) : 4942 - 4946
  • [37] TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor
    Nahacka, Zuzana
    Svadlenka, Jan
    Peterka, Martin
    Ksandrova, Marie
    Benesova, Simona
    Neuzil, Jiri
    Andera, Ladislav
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2018, 1865 (03): : 522 - 531
  • [38] TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2
    Tamada, Taro
    Shinmi, Daisuke
    Ikeda, Masahiro
    Yonezawa, Yasushi
    Kataoka, Shiro
    Kuroki, Ryota
    Mori, Eiji
    Motoki, Kazuhiro
    SCIENTIFIC REPORTS, 2015, 5
  • [39] Human monoclonal antibodies to TRAIL receptors R1 and R2 effectively induce apoptosis in human myeloma cells.
    Ozaki, S
    Sekimoto, E
    Tanaka, Y
    Ohshima, T
    Shibata, H
    Hashimoto, T
    Abe, M
    Motoki, K
    Ishida, I
    Kataoka, S
    Matsumoto, T
    BLOOD, 2004, 104 (11) : 919A - 919A
  • [40] Tacrolimus(FK506) Induced Cytotoxicity Via TRAIL-R1 (DR4) or TRAIL-R2 (DR5) in Jurkat Cells
    Choi, S.
    Chung, S.
    TRANSPLANTATION, 2014, 98 : 284 - 284
12345